Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Skin cancer
Closed
Phase 3
This study is looking at a type of called ATL001 by itself and in combination with nivolumab.
It is open to people with melanoma that has either:
spread to another part of the body (advanced melanoma) or
come back after treatment
Recruitment start: 15 August 2019
Recruitment end: 3 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Samra Turajlic
Achilles Therapeutics
Last reviewed: 22 Oct 2024
CRUK internal database number: 17801